Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study

References

• CammAJLipGYDe CaterinaR2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm AssociationEur Heart J201233212719719
   Google Scholar
• ChughSSHavmoellerRNarayananKWorldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 StudyCirculation2014129883784724345399
   PubMed Web of Science ®Google Scholar
• GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in Atrial Fibrillation (ATRIA) StudyJAMA2001285182370237511343485
   PubMed Web of Science ®Google Scholar
• FeinbergWMBlackshearJLLaupacisAKronmalRHartRGPrevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implicationsArch Intern Med199515554694737864703
   PubMedGoogle Scholar
• CammAJKirchhofPLipGYGuidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)Europace201012101360142020876603
   PubMed Web of Science ®Google Scholar
• PriscoDCenciCSilvestriEEmmiGBarniniTTamburiniCThe risk stratification in atrial fibrillationIntern Emerg Med20127suppl 3S233S24023073863
   PubMedGoogle Scholar
• RavieleADisertoriMAlboniP webpage on the InternetLinee guida AIAC per la gestione e il trattamento della fibrillazione atriale. Aggiornamento 2013G Ital Cardiol2013 Available from: http://www.giornaledicardiologia.it/articoli.php?archivio=yes&vol_id=1234&id=13660Accessed April 27, 2017
   Google Scholar
• FusterVRydenLECannomDS2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyJ Am Coll Cardiol20115711e101e19821392637
   PubMed Web of Science ®Google Scholar
• CurtisABPractice implications of the atrial fibrillation guidelinesAm J Cardiol2013111111660167023507710
   PubMed Web of Science ®Google Scholar
• WasmerKEckardtLManagement of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelinesEuropace201113101368137421712281
   PubMed Web of Science ®Google Scholar
• AndersonJLHalperinJLAlbertNMManagement of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol201361181935194423558044
   PubMed Web of Science ®Google Scholar
• HylekEMGoASChangYEffect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillationN Engl J Med2003349111019102612968085
   PubMed Web of Science ®Google Scholar
• OgilvieIMNewtonNWelnerSACowellWLipGYUnderuse of oral anticoagulants in atrial fibrillation: a systematic reviewAm J Med20101237638.e4645.e420609686
   PubMed Web of Science ®Google Scholar
• FerroDLoffredoLPolimeniLVioliFUnderuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in ItalyIntern Emerg Med200721242817551680
   PubMed Web of Science ®Google Scholar
• MonteSMacchiaAPellegriniFAntithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillationEur Heart J200627182217222316935869
   PubMed Web of Science ®Google Scholar
• WilkeTGrothAPfannkucheMReal life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-useJ Thromb Thrombolysis20154019710725218507
   PubMed Web of Science ®Google Scholar
• MazzagliaGFilippiAAlacquaMA national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary careThromb Haemost2010103596897520216987
   PubMed Web of Science ®Google Scholar
• Zoni-BerissoMFilippiALandolinaMFrequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study)Am J Cardiol2013111570571123273528
   PubMed Web of Science ®Google Scholar
• Italian Medicine Agency (AIFA)Guideline for the Classification and Conduction of the Observational Studies on Medicines2017 Available from: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdfAccessed April 27, 2017
   Google Scholar
• ShahMAvgil TsadokMJackeviciusCAWarfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysisCirculation2014129111196120324452752
   PubMed Web of Science ®Google Scholar
• Degli EspostiLSangiorgiDPerroneVAdherence and resource use among patients treated with biologic drugs: findings from BEETLE studyClinicoecon Outcomes Res2014640140725258545
   PubMedGoogle Scholar
• GerthWCCompliance and persistence with newer antihypertensive agentsCurr Hypertens Rep20024642443312419170
   PubMed Web of Science ®Google Scholar
• HeeringaJvan der KuipDAHofmanAPrevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam studyEur Heart J200627894995316527828
   PubMed Web of Science ®Google Scholar
• LeviMHobbsFDJacobsonAKImproving antithrombotic management in patients with atrial fibrillation: current status and perspectivesSemin Thromb Hemost200935652754219787556
   PubMed Web of Science ®Google Scholar
• Di PasqualeGMathieuGMaggioniAPCurrent presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF studyInt J Cardiol201316762895290322884698
   PubMed Web of Science ®Google Scholar
• NieuwlaatRCapucciALipGYAntithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on atrial fibrillationEur Heart J200627243018302616731536
   PubMed Web of Science ®Google Scholar
• MurphyNFSimpsonCRJhundPSA national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in ScotlandHeart200793560661217277353
   PubMed Web of Science ®Google Scholar
• FribergLHammarNRinghMPetterssonHRosenqvistMStroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)Eur Heart J200627161954196416847008
   PubMed Web of Science ®Google Scholar
• Osservatorio ARNO cardiovascolare [webpage on the Internet]La prevenzione secondaria dopo un evento di sindrome coronarica acuta2017 Available from: http://www.cineca.it/it/pubblicazione/osservatorio-arno-cardiovascolare-la-prevenzione-secondaria-dopo-un-evento-di-sindromeAccessed May 11, 2017
   Google Scholar
• CammAJPintoFJHankeyGJAndreottiFHobbsFDRWriting Committee of the Action for Stroke Prevention AllianceNon-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementationEuropace20151771007101726116685
   PubMed Web of Science ®Google Scholar
• GensiniGFDi PasqualeGVaccaroCMIndagine Censis sulla conoscenza in Italia della fibrillazione atriale a livello dei cittadini, dei medici di medicina generale e dei pazienti. [A Censis survey on atrial fibrillation awareness in the general population and among general practitioners and affected patients in Italy]G Ital Cardiol Rome20141513743 Italian24503733
   PubMedGoogle Scholar
• KirleyKRaoGBauerVMasiCThe role of NOACs in atrial fibrillation management: a qualitative studyJ Atrial Fibrillation2016911416
   PubMedGoogle Scholar
• De CaterinaRRendaGSangiuoloRSteering Committee del Registro Europeo PREFER in AF (vedi Appendice 1)La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: dati al basale del Registro Europeo PREFER in AF. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry]G Ital Cardiol Rome201415299109 Italian24625849
   PubMedGoogle Scholar
• ForslundTWettermarkBHjemdahlPComparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillationEur J Clin Pharmacol201672332933826613954
   PubMed Web of Science ®Google Scholar
• BrownTMSiuKWalkerDPladevall-VilaMSanderSMordinMDevelopment of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillationJ Manag Care Pharm201218535136222663168
   PubMedGoogle Scholar
• ChenSYWuNGulsethMOne-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent eventsJ Manag Care Pharm201319429130123627575
   PubMed Web of Science ®Google Scholar
• HessPLMirroMJDienerHCAddressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012Am Heart J20141683239.e1247.e125173533
   PubMed Web of Science ®Google Scholar
• Gruppo Di Lavoro Artiocolo 29 per la protezione dei datiParere 05/2014 sulle tecniche di anonimizzazione, adottato il 10 aprile 2014 [Working Group Article 29 for protection of data. Opinion 05/2014 on the anonymization techniques, Adopted on 10 April 2014] Available from http://ec.europa.eu/justice/data-protection/article-29/documentation/opinion-recommendation/files/2014/wp216_it.pdfAccessed June 14, 2017 Italian
   Google Scholar